References


Amerithrax Investigative Summary - United States Department of Justice. (n.d.). Retrieved August 8, 2022, from https://www.justice.gov/archive/amerithrax/docs/amx-investigative-summary.pdf

Animal Health Emergency Management. USDA APHIS | Animal Health Emergency Management. (n.d.). Retrieved August 25, 2022, from https://www.aphis.usda.gov/aphis/ourfocus/animalhealth/emergency-management

Anthrax facts (fact sheet) - Minnesota Dept. of Health. (n.d.). Retrieved September 2, 2022, from https://www.health.state.mn.us/diseases/anthrax/anthrax.html

Avril, A., Tournier, J.-N., Paucod, J.-C., Fournes, B., Thullier, P., & Pelat, T. (2022). Antibodies against anthrax toxins: A long way from Benchlab to the bedside. Toxins, 14(3), 172. https://doi.org/10.3390/toxins14030172

Best Practices for Hospital-Based First Receivers of Victims from Mass Casualty Incidents Involving the Release of Hazardous Substances. OSHA 3249-08N 2005. Retrieved 8/11/2022 from https://www.osha.gov/sites/default/files/publications/osha3249.pdf

BIOTERRORISM-DOMESTIC WEAPONS OF MASS DESTRUCTION, 106th Cong. 46-47 (2000) (Statement of Donald A. Henderson)

Bioterrorism. INTERPOL. (n.d.). Retrieved August 8, 2022, from https://www.interpol.int/en/Crimes/Terrorism/Bioterrorism

Botulism (2018). The Center For Food Security and Public Health (CFSPH). Retrieved September 6, 2022, from https://www.cfsph.iastate.edu/Factsheets/pdfs/botulism.pdf

Brown, L. (2014). Smallpox Preparedness Planning: Understanding the Strategic National Stockpile and Potential Weaponization. National Association of County and City Health Officials (NACCHO). Retrieved 8/20/2022 from https://www.naccho.org/blog/articles/smallpox-preparedness-planning-understanding-the-strategic-national-stockpile-and-potential-weaponization

Bugert, J.J., Hucke, F., Zanetta, P. et al. Antivirals in medical biodefense. Virus Genes 56, 150–167 (2020). https://doi.org/10.1007/s11262-020-01737-5

Carus, W. S.,(2001) National Defense Univ Washington Dc.. Bioterrorism and biocrimes: The illicit use of biological agents since 1900. DTIC. Retrieved August 23, 2022, from https://apps.dtic.mil/sti/citations/ADA402108

CDC. (2020) Anthrax. Anthrax as a bioterrorism weapon. Retrieved September 2, 2022, from https://www.cdc.gov/anthrax/bioterrorism/index.html

CDC. (2016).  Anthrax vaccination recommendations. Centers for Disease Control and Prevention. Retrieved August 14, 2022, from https://www.cdc.gov/vaccines/vpd/anthrax/hcp/recommendations.html

CDC. (2018). CDC's laboratory response to suspicious substances|laboratory information. Centers for Disease Control and Prevention. Retrieved August 30, 2022, from https://emergency.cdc.gov/labissues/substanceresponse.asp

CDC. (2021) Ebola (Ebola Virus Disease). Ebola Treatment, retrieved from: http://www.cdc.gov/vhf/ebola/treatment/index.html

CDC. (2018) Emergency Preparednes and Responses. Bioterrorism Agents/Diseases. Retrieved 9/6/2022 from: https://emergency.cdc.gov/agent/agentlist-category.asp#a

CDC. (2018) National Syndromic Surveillance Program. What is syndromic surveillance? about the NSSP community of Practice. (n.d.). Retrieved August 30, 2022, from https://www.cdc.gov/nssp/documents/NSSP-overview.pdf

CDC Newsroom (2014) CDC Media Statement on Newly Discovered Smallpox Specimens. Retrieved 9/1/2022 from https://www.cdc.gov/media/releases/2014/s0708-NIH.html

CDC Newsroom (2021). CDC Testing Shows Commercial Lab Vials Contain No Trace of Virus Known to Cause Smallpox. Retrieved 9/1/2022 from https://www.cdc.gov/media/releases/2021/s1119-smallpox-vials.html

CDC. Plague. Ecology & Transmission (2021). Retrieved 9/6/2022 from https://www.cdc.gov/plague/symptoms/index.html

CDC. Plague. Ecology & Transmission (2019) Retrieved 9/6/2022 from https://www.cdc.gov/plague/transmission/index.html

CDC. Smallpox. History of Smallpox. (n.d.) retrieved on 8/21/2022 from https://www.cdc.gov/smallpox/history/history.html

CDC. Smallpox. The Threat. (n.d.). Retrieved 8/20/2022 from https://www.cdc.gov/smallpox/bioterrorism/public/threat.html

CDC. Smallpox. Treatment. (n.d.). Retrieved 8/20/2022 from https://www.cdc.gov/smallpox/clinicians/treatment.html

CDC. (2022). Tularemia. For clinicians. Retrieved August 17, 2022, from https://www.cdc.gov/tularemia/clinicians/index.html

CDC. Tularemia. Transmission (2018). Retrieved 9/6/2022 from https://www.cdc.gov/tularemia/transmission/index.html

CDC. Viral Hemorrhagic Fevers (VHFs). What are VHFs? (Reviewed 2021) From https://www.cdc.gov/vhf/index.html

Cenciarelli, O., Riley, P. W., & Baka, A. (2019). Biosecurity Threat Posed by Botulinum Toxin. Toxins, 11(12), 681. https://doi.org/10.3390/toxins11120681

Chesnokova, O. N., McPherson, S. A., Steichen, C. T., & Turnbough, C. L. (2009). The spore-specific alanine racemase of bacillus anthracis and its role in suppressing germination during spore development. Journal of Bacteriology, 191(4), 1303–1310. https://doi.org/10.1128/jb.01098-08

CIDRAP News. (2019). Botulism. CIDRAP. Retrieved September 6, 2022, from https://www.cidrap.umn.edu/infectious-disease-topics/botulism#overview&1-8

Clark, R. (1992) OSHA. Standard Interpretations / Training requirements for hospital personnel involved in an emergency response of a hazardous substance. Retrieved 8/31/2022 from https://www.osha.gov/laws-regs/standardinterpretations/1992-10-27-1

Department of Homeland Security (DHS) (2022). Summary of Terrorism Threat to the United States. Retrieved 8/5/2022 from
https://www.dhs.gov/ntas/advisory/national-terrorism-advisory-system-bulletin-june-7-2022

Dhaked, R. K., Singh, M. K., Singh, P., & Gupta, P. (2010). Botulinum toxin: bioweapon & magic drug. The Indian journal of medical research, 132(5), 489–503.

Ebanga. Center for Drug Evaluation and Research. (2020). FDA approves treatment for ebola virus. U.S. Food and Drug Administration. Retrieved August 25, 2022, from https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-ebola-virus

Ervebo (2019). First FDA-approved vaccine for the prevention of ebola virus disease, marking a critical milestone in public health preparedness and response. U.S. Food and Drug Administration. Retrieved August 25, 2022, from https://www.fda.gov/news-events/press-announcements/first-fda-approved-vaccine-prevention-ebola-virus-disease-marking-critical-milestone-public-health

Federal Bureau of Investigation. What We Investigate. WMD. News and Press Releases. Retrieved 8/7/2022 from:  https://www.fbi.gov/investigate/wmd/news

FDA . CNJ-016. (2005). Vaccinia Immune Globulin Intravenous (Human), sterile solution Label. Retrieved 8/21/2022 from https://www.fda.gov/media/77004/download

FDA. Vaccines. Anthrax (2018). Retrieved 8/13/2022 from: Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, et al. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis [Internet]. 2014 Feb [date cited]. http://dx.doi.org/10.3201/eid2002.130687

FDA Botox Label (1989). Retrieved 8/15/2022, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103000s5232lbl.pdf

Ghahremani, M., Rooddehghan, Z., Varaei, S. et al. (2022). Knowledge and practice of nursing students regarding bioterrorism and emergency preparedness: comparison of the effects of simulations and workshop. BMC Nurs 21, 152 . https://doi.org/10.1186/s12912-022-00917-y 

Global Biodefense. (2021). U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID, 2021) - Directory of Organizations and Experts. Retrieved August 8, 2022, from https://globalbiodefense.com/directory/name/u-s-army-medical-research-institute-of-infectious-diseases-usamriid/

Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, et al. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis [Internet]. 2014 Feb [date cited]. http://dx.doi.org/10.3201/eid2002.130687

Illinois Department of Public Health (IDPH )(n.d.) Alphaviruses. Retrieved 8/26/2022 from http://www.idph.state.il.us/Bioterrorism/factsheets/alphaviruses.htm

Inmazeb. FDA approves first treatment for ebola virus. U.S. Food and Drug Administration (2020). Retrieved August 25, 2022, from https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-ebola-virus

Ippolito, G., Feldmann, H., Lanini, S. et al. (2012). Viral hemorrhagic fevers: advancing the level of treatment. BMC Med 10, 31 (2012). Retrieved 8/25/2022 from https://doi.org/10.1186/1741-7015-10-31

Joseph AA, Fasipe OJ, Joseph OA, Olatunji OA. (2022). Contemporary and emerging pharmacotherapeutic agents for the treatment of Lassa viral haemorrhagic fever disease. J Antimicrob Chemother. 29;77(6):1525-1531. doi: 10.1093/jac/dkac064.

Kiger, P. J. (2018, November 15). Did colonists give infected blankets to Native Americans as biological warfare? History.com. Retrieved August 17, 2022, from https://www.history.com/news/colonists-native-americans-smallpox-blankets

Madu, I. G., Files, M., Gharaibeh, D. N., Moore, A. L., Jung, K. H., Gowen, B. B., Dai, D., Jones, K. F., Tyavanagimatt, S. R., Burgeson, J. R., Korth, M. J., Bedard, K. M., Iadonato, S. P., & Amberg, S. M. (2018). A potent Lassa virus antiviral targets an arenavirus virulence determinant. PLoS pathogens, 14(12), e1007439. https://doi.org/10.1371/journal.ppat.1007439

McClain, D. (1997) Chapter 27 smallpox - globalsecurity.org. Retrieved August 20, 2022, from https://www.globalsecurity.org/wmd/library/report/1997/cwbw/Ch27.pdf

Minnesota Department of Health (MDH)(2019). Viral Hemorrhagic Fevers (VHFs) Fact Sheet. Retrieved 8/23/2022 from https://www.health.state.mn.us/diseases/vhf/vhf.html#weapons

MMWR (2015) Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident CDC Recommendations. Retrieved 9/2/2022 from https://www.cdc.gov/mmwr/pdf/rr/rr6404.pdf

Nelson CA, Meaney-Delman D, Fleck-Derderian S, Cooley KM, Yu PA, Mead PS. Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response. MMWR Recomm Rep 2021;70(No. RR-3):1–27. DOI: http://dx.doi.org/10.15585/mmwr.rr7003a1

Poulain, B., & Popoff, M. R. (2019). Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?. Toxins, 11(1), 34. https://doi.org/10.3390/toxins11010034

Rao, A. K., Sobel, J., Chatham-Stephens, K., & Luquez, C. (2021). Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 70(2), 1–30. https://doi.org/10.15585/mmwr.rr7002a1

Ready or not 2022: Protecting the public's health from diseases, disasters, and bioterrorism. tfah. (n.d.). Retrieved August 7, 2022, from https://www.tfah.org/report-details/ready-or-not-2022/

Recognizing bioterrorism. Disease Prevention and Control, San Francisco Department of Public Health. (2018, January 2). Retrieved September 6, 2022, from https://www.sfcdcp.org/health-alerts-emergencies/recognize-an-illness-associated-with-bioterrorism/

Salam, A. P., Rojek, A., Cai, E., Raberahona, M., & Horby, P. (2020). Deaths Associated with Pneumonic Plague, 1946-2017. Emerging infectious diseases, 26(10), 2432–2434. https://doi.org/10.3201/eid2610.191270

Simpson, C. (2013) The Case of the Missing Deadly Virus Is Only a Problem If You Own Rats. The Atlantic. https://www.theatlantic.com/national/archive/2013/03/missing-deadly-virus-texas/317019/

Sweeney, D. A., Cui, X., Solomon, S. B., Vitberg, D. A., Migone, T. S., Scher, D., Danner, R. L., Natanson, C., Subramanian, G. M., & Eichacker, P. Q. (2010). Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines. The Journal of infectious diseases, 202(12), 1885–1896. https://doi.org/10.1086/657408

TFAH’s Ready or Not 2022: Protecting the Public’s Health from Diseases, Disasters, and Bioterrorism report calls for urgent investment to create a public health system able to protect all Americans’ health during emergencies. https://www.tfah.org/wp-content/uploads/2022/03/2022_ReadyOrNot_Fnl.pdf

Treadwell, T. A., Koo, D., Kuker, K., & Khan, A. S. (2003). Epidemiologic clues to bioterrorism. Public health reports (Washington, D.C. : 1974), 118(2), 92–98. https://doi.org/10.1093/phr/118.2.92

United Nations (2022) Marburg virus disease: origins and symptoms. Retrieved 8/25/2022 from https://unric.org/en/marburg-virus-disease-origins-and-symptoms/

U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID, 2021) - directory of organizations and experts. Global Biodefense. (2021). Retrieved August 8, 2022, from https://globalbiodefense.com/directory/name/u-s-army-medical-research-institute-of-infectious-diseases-usamriid/

US WorldMeds - Mechanism of Action (2009). Amerra Medical. Youtube video https://youtu.be/R-A8YI7Ik4g?t=1

Woolsey C, Cross RW, Agans KN, et al.(2022). A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge. Plos Neglected Tropical Diseases. 16(5):e0010433. DOI: 10.1371/journal.pntd.0010433. Retrieved 8/26/2022 from https://europepmc.org/article/pmc/pmc9182267

World Health Organization (WHO, 2021). Ebola virus disease. Retrieved 8/25/2022 from https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease

World Health Organization (WHO, 2020). Ebola Virus Disease Democratic Republic of the Congo. External Situation Report 98. Retrieved 2/25/2022 from https://apps.who.int/iris/bitstream/handle/10665/332654/SITREP_EVD_DRC_20200623-eng.pdf

World Health Organization. (1970). HEALTH ASPECTS OF CHEMICAL AND BIOLOGICAL WEAPONS. Retrieved September 2, 2022, from https://iris.wpro.who.int/?sequence=1

World Health Organization (WHO, 2017) Lassa fever. Retrieved 8/25/2022 from https://www.who.int/news-room/fact-sheets/detail/lassa-fever